Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$556K Sell
5,721
-75
-1% -$6.86K 0.07% 97
2025
Q4
$512K Sell
5,796
-75
-1% -$6.83K 0.06% 128
2025
Q3
$528K Buy
5,871
+189
+3% +$15.3K 0.07% 127
2025
Q2
$431K Buy
5,682
+209
+4% +$15.5K 0.06% 137
2025
Q1
$391K Sell
5,473
-722
-12% -$56.3K 0.07% 140
2024
Q4
$543K Buy
6,195
+125
+2% +$10.9K 0.1% 94
2024
Q3
$508K Sell
6,070
-300
-5% -$24K 0.1% 105
2024
Q2
$484K Sell
6,370
-36
-0.6% -$2.66K 0.1% 110
2024
Q1
$460K Buy
+6,406
New +$459K 0.1% 114

Other funds holding SRE

MJP Associates's SRE Position: Q1 2026 in Review

MJP Associates reduced its Sempra (SRE) stake by 1.3% in Q1 2026, selling an estimated $6.86K and leaving 5,721 shares worth $556K. The position accounts for 0.07% of the portfolio, ranked #97.

MJP Associates first reported a position in SRE in Q1 2024 and has held it in 9 quarters since. 1,264 funds tracked by Wall St. Rank hold SRE as of Q1 2026.

  • MJP Associates held 5,721 shares of Sempra worth $556K as of Q1 2026.
  • MJP Associates sold 75 Sempra shares in Q1 2026, an estimated $6.86K.
  • Sempra made up 0.07% of MJP Associates's portfolio in Q1 2026, its #97 holding.
  • MJP Associates first reported a position in Sempra in Q1 2024 and has held it in 9 quarters since.
  • 1,264 funds tracked by Wall St. Rank held Sempra as of Q1 2026.

Based on MJP Associates's 13F filing for Q1 2026, filed 5 May 2026.